融资计划 - 公司宣布进行非经纪私募融资，计划发行最多9,433,000个单位，每个单位价格为C$0.53，总融资额约为4,999,490加元 [1] - 每个单位包括一股次级投票股（SVS）和半份SVS购买认股权证（Warrant），每份认股权证可在24个月内以C$0.67的价格购买一股SVS [1] - 如果SVS在TSX Venture Exchange上的价格在认股权证发行后4个月零1天后的任何连续10个交易日内超过C$1.00，公司可选择提前终止认股权证 [1] 融资用途 - 融资净收益将用于销售和增长计划，特别是围绕“数字孪生”技术，包括营销成本、合作伙伴开发、佣金成本和行业费用 [4] - 部分资金将用于一般营运资金和公司开支，包括董事和高级管理人员费用、承包商和咨询费用、专业费用以及一般行政支出 [4] 融资条件 - 融资完成需满足某些条件，包括获得所有必要的批准并向TSX Venture Exchange提交所有所需文件 [5] 财务顾问协议 - 公司与Roth Canada, Inc.签订财务顾问协议，Roth将提供战略咨询服务，并获得125,000美元的现金费用 [7] 公司业务 - 公司通过其实时数字操作软件edgeCore™帮助客户维持情境感知并加速行动，该软件将多个软件应用程序和数据源整合到一个称为“数字孪生”的沉浸式体验中 [8] - 通过edgeCore，客户可以提高利润率和敏捷性，快速整合孤立的系统和数据，应对业务、技术和跨领域操作中不断变化的情况 [8] 融资豁免 - 根据加拿大国家工具45-106（NI 45-106）的上市发行人融资豁免条款，融资单位将向加拿大各省（魁北克除外）的居民出售 [2] - 根据适用的加拿大证券法，根据上市发行人融资豁免发行的证券不受持有期限制 [2] 投资者信息 - 与融资相关的发行文件可在公司网站和SEDAR+上查阅，潜在投资者应在做出投资决策前阅读该文件 [3]

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that ECRI – leaders in advancing evidence-based healthcare globally - have completed updated Clinical Evidence Assessments of ALLEVYN LIFE Sacrum Foam Dressings and the LEAF Patient Monitoring System. In their latest reports, ECRI upgraded its Evidence Bar ratings for both to favorable* after assessing the most recently published clinical evidence and key outcomes for pressure injury prevention. The ECRI Evidence Bar pro ...

Vancouver, British Columbia--(Newsfile Corp. - December 16, 2024) - Trilogy AI Corp. (formerly, Ambari Brands Inc.) (CSE: TRAI) (OTCQB: TRAIF) (FSE: Y920) (the "Company") is pleased to announce (i) a non-brokered private placement offering of up to 7,000,000 common shares in the authorized share structure of the Company ("Common Shares") at a price of C$0.07 per Common Share, for aggregate proceeds of up to C$490,000 (the "LIFE Offering"), and (ii) an additional (non-LIFE) private placement (the "Private P ...

From an On-Field Wedding to Broadcasting From the World's Largest Bowl of Cheez-It Crackers – Fans Will to Live Out their Wildest College Football 'Fantaseez' with the Help of New CFO, Reality Star Kordell BeckhamCHICAGO, Dec. 2, 2024 /PRNewswire/ -- Bowl season is almost here, and the Cheez-It® Citrus Bowl is bringing more absurd experiences than ever before. College football fans have wild game day fantasies they can only dream about – like proposing on the jumbotron or delivering a halftime peptalk to th ...

文章核心观点 - BluMetric Environmental Inc. 宣布与Clarus Securities Inc.达成协议，进行一项私募配售，发行最多4,375,000股普通股，筹集最多3,500,000美元的资金。此外，公司还计划进行一项非经纪人的私募配售，发行最多625,000股普通股，筹集500,000美元的资金。这些资金将用于加强公司财务状况和偿还运营信用额度，并支持公司扩大生产能力和参与更大规模的水和废水项目[1][5][6] 私募配售详情 - 公司将通过Clarus Securities Inc.作为主要代理和唯一账簿管理人，进行一项最佳努力私募配售，发行最多4,375,000股普通股，每股价格为0.80美元，筹集最多3,500,000美元的资金[1] - 该私募配售将根据国家文书45-106中的上市发行人融资豁免条款进行，适用于加拿大所有省份的购买者，但不包括魁北克省[2] - Clarus Securities Inc.将获得6%的现金佣金和等同于6%的经纪人认股权证，每个认股权证可购买一股普通股，价格为0.80美元，有效期为18个月[3] - 与私募配售相关的发行文件可在www.sedarplus.ca和公司网站www.blumetric.ca上获取[4] 非经纪人私募配售详情 - 公司计划进行一项非经纪人的私募配售，发行最多625,000股普通股，每股价格为0.80美元，筹集500,000美元的资金[5] - 该非经纪人私募配售将面向加拿大所有省份和地区的合格投资者，包括认可投资者[5] - 非经纪人私募配售的普通股将有4个月零一天的持有期[5] 资金用途 - 公司计划将私募配售和非经纪人私募配售的净收益用于一般公司和运营资本用途，以加强公司财务状况和偿还运营信用额度[6] - 公司CEO Scott MacFabe表示，这些资金将有助于公司寻求机会继续扩大生产能力，并参与更大规模的水和废水项目[6] 公司背景 - BluMetric Environmental Inc.是一家公开交易的环境咨询和工程公司，拥有超过220名员工，在十个办公室运营，拥有超过45年的专业经验[8] - 公司专注于为商业和工业、军事、采矿和政府客户提供可持续的环境和水挑战解决方案[9]

MONTREAL, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cerro de Pasco Resources Inc. (CSE: CDPR) (OTCQB: GPPRF) (FRA: N8HP) (“CDPR” or the “Corporation”) announces that is has filed an amended and restated offering document dated November 19, 2024 (the “A&R Offering Document”) in connection with its previously announced brokered “best-efforts” private placement led by SCP Resource Finance LP, on behalf of itself and a syndicate of agents (hereinafter referred to collectively as the “Agents”). Pursuant to the A&R Offer ...

公司融资情况 - 公司VERSES AI Inc完成了此前宣布的非经纪私募发行（LIFE Offering）的第二批融资 总收益为512800美元第一批于11月8日完成 总收益为2903850美元11月8日公司还完成了一笔特殊认股权证的非经纪私募发行 总收益为1800000美元[1] - 第二批LIFE Offering中公司以每股0.50美元的发行价发行了1025600个LIFE Units每个LIFE Unit包含一股A类次级投票股和0.5股认股权证 认股权证持有者有权以每股0.70美元的行使价购买一股股票 有效期为36个月[2] - 与第二批LIFE Offering相关公司向某些发现者和顾问支付了总计30082加元的现金佣金 并发行了总计60164份补偿认股权证 每份补偿认股权证可在发行价下转换为一个补偿单元 有效期为36个月[5] 融资相关规定 - LIFE Offering利用了NI 45 - 106第5A部分的上市发行人融资豁免（Exemption） 根据该豁免发行的股票是可自由交易的上市股权证券 不受任何持有期限制[3] - LIFE Offering在加拿大除魁北克省以外的所有省份根据豁免进行 在美国根据美国1933年证券法D条例的注册要求豁免进行 并在加拿大和美国以外的其他司法管辖区进行 只要在这些司法管辖区没有招股说明书备案或类似义务LIFE Units根据加拿大证券法不受转售限制 但向美国人士发售和出售的LIFE Units（及其相关股票认股权证和认股权证股票）将被视为1933年法案下的受限证券[4] 融资用途 - LIFE Offering的净收益将用于一般营运资金目的 为持续运营提供资金以及为研发提供资金 包括Genius的开发[6] 公司概况 - 公司是一家认知计算公司 正在构建以自然智慧为蓝本的下一代智能软件系统 旗舰产品Genius是一个供开发者生成智能软件代理的工具包 可增强现有应用程序的推理规划和学习能力[8]

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”) is pleased to announce that it closed the first tranche of its previously announced non-brokered private placement of 5,807,700 units of the Company (the "LIFE Units") at a price of $0.50 per LIFE Unit (the “Offering Price”) for aggregate gross proceeds of $2,903,850 (the ...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 08, 2024 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQX:VRSSF) (“VERSES” or the “Company”) is pleased to announce that it closed its previously announced non-brokered private placement of 3,600,000 special warrants of the Company (the “Special Warrants”) at a price of $0.50 (the “Offering Price”) per Special Warrant for aggregate gross proceeds of $1.8 million ...

NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Globe Life, Inc. (NYSE: GL) on behalf of long-term stockholders following a class action complaint that was filed against Globe Life on April 30, 2024 with a Class Period from May 8, 2019 and April 10, 2024. Our investigation concerns whether the board of directors of Globe Life have breached their fiduciary duties to the company. Globe Life, ...